ProfileGDS5678 / 1430706_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 38% 39% 39% 39% 38% 41% 39% 38% 40% 38% 39% 40% 39% 39% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 12.9075238
GSM967853U87-EV human glioblastoma xenograft - Control 22.894939
GSM967854U87-EV human glioblastoma xenograft - Control 32.8975539
GSM967855U87-EV human glioblastoma xenograft - Control 42.842439
GSM967856U87-EV human glioblastoma xenograft - Control 52.816438
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 13.0268941
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 22.9591939
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 32.8634938
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 42.8885440
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 12.8584638
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 22.8871739
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 32.8907640
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 42.9079539
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 52.8928539